Winship Oncology Nursing Symposium features locally, nationally and internationally recognized oncology leaders

The annual Winship Oncology Nursing Symposium, “Charting Your Path as an Oncology Nurse: Tales from the Trenches,” will be held Saturday, June 11. The virtual continuing education program, which offers up to 20 contact hours, is complimentary for Emory employees and discounted for participants from other institutions. Pictured: a view from the symposium's virtual lobby.

Video: Oncology Nursing Month spotlight with Terri Tayco

Meet Terri Tayco, MSN, MHA, RN, OCN, a Winship unit nurse educator in inpatient oncology at Emory University Hospital. In this video, Tayco talks about Winship's high level of care and expertise as an academic medical center, working toward a shared goal with patients and colleagues and feeling recognized as an integral part of the care team.

Watch Video

Emory Proton Therapy Center earns patient experience awards

Winship’s Emory Proton Therapy Center accepted four awards for high performance on patient satisfaction surveys from Emory Healthcare's Physician Group Practice: Most Improved Patient Satisfaction, The Patients' Choice Award - LTR, The Lending Ear Award, and Highest Teamwork Award.

About the Center

McCullough receives Emory’s Distinguished Teaching Award

Winship investigator Lauren McCullough, PhD, MSPH, is among the recipients of the Emory Provost’s Distinguished Teaching Award for Excellence in Graduate and Professional Education for 2022. One faculty member in each of the seven graduate and professional schools is given the award in recognition of the important role of exceptional teaching in graduate and professional education.

Faculty honored on Educator Appreciation Day

Twelve Winship faculty received special recognition from Emory School of Medicine on Educator Appreciation Day: Richard Castillo, PhD, DABR, Karmella Haynes, PhD, Byron Au-Yeung, PhD, Zachary Bercu, MD, RPVI, Kyle T. Bradley, MD, MS, Karen Conneely, PhD, Christopher Filson, MD, MS, Adriana Ioachimescu, MD, PhD, FACE, Mary Jo Lechowicz, MD, Daniel Lubin, MD, Meredith Maxwell, MD, and Joshua H. Winer, MD.

View Honorees

Eaton receives Red Journal's Outstanding Reviewer Award

Winship radiation oncologist Bree Eaton, MD, has received a 2022 Outstanding Reviewer Award from the International Journal of Radiation Oncology, Biology, Physics. Known as Red Journal, the journal is the official scientific publication of the American Society for Radiation Oncology.

View Profile

Wynne selected for Holman Research Pathway

Emory radiation oncology resident Jacob Wynne, MD, has been selected to participate in the American Board of Radiology B. Leonard Holman Research Pathway. The program will enable Wynne to dedicate a portion of his residency to a mentored research project focused on machine learning methods to improve radiation therapy.

School of Medicine Diversity Week to celebrate inclusion and belonging

Emory School of Medicine’s Diversity Week, May 16-20, is a celebration of the broad range of identities and experiences that make up Emory’s diverse community. All events are free and open to all and feature lectures, breakout sessions, poster presentations and social activities, including a block party at noon on Friday, May 20.

Learn More

Radiation Oncology welcomes new physician and medical physicist residents

The Emory Department of Radiation Oncology welcomes three physician residents and three medical physics residents to its physician and medical physics residency programs. Pictured (clockwise from top left): Matthew J. Case, MD, Nicholas A. Bader, MD, Soumya Unnikrishnan, MD, Elham Abouei, PhD, Wang Qianxia, PhD, and Moeen Meftahi, PhD.

Below are four selected Winship publications out of 52 published over the past week:

Dimopoulos MA, Richardson PG, Bahlis NJ, Grosicki S, Cavo M, Beksaç M, Legieć W, Liberati AM, Goldschmidt H, Belch A, Magen H, Larocca A, Laubach JP, Petrucci MT, Reece D, White D, Mateos MV, Špička I, Lazaroiu M, Berdeja J, Kaufman JL, Jou YM, Ganetsky A, Popa McKiver M, Lonial S, Weisel K. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. The Lancet Haematology. 2022; PubMed PMID: 35550060.

View in PubMed

Badve SS, Penault-Llorca F, Reis-Filho JS, Deurloo R, Siziopikou KP, D'Arrigo C, Viale G. Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130. Journal of the National Cancer Institute. 2022; 114(5):664-675. PubMed PMID: 34286340.

View in PubMed

Varghese B, Lynch L, Vriend LE, Draganov D, Clark JM, Kissick HT, Varghese S, Sanda MG, Dranoff G, Arredouani MS, Balk SP, Exley MA. Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model. Cancer Immunology, Immunotherapy. 2022; PubMed PMID: 35523889.

View in PubMed

Summers RJ, Castellino SM, Porter CC, MacDonald TJ, Basu GD, Szelinger S, Bhasin MK, Cash T, Carter AB, Castellino RC, Fangusaro JR, Mitchell SG, Pauly MG, Pencheva B, Wechsler DS, Graham DK, Goldsmith KC. Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care. JCO Precision Oncology. 2022; 6:e2100451. PubMed PMID: 35544730.

View in PubMed